Page last updated: 2024-10-18

dihydroxyphenylalanine and Benign Neoplasms

dihydroxyphenylalanine has been researched along with Benign Neoplasms in 31 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference
"In cancer patients with hypersplenism-related thrombocytopenia, PSAE is a safe intervention that effects a durable elevation in platelet counts across a range of malignancies and following the re-initiation of chemotherapy."2.73 ( Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I, 2007)
"Chemotherapy treatments for cancer are always accompanied by a low concentration of drug delivered in the tumor area and severe side effects including systemic toxicity."1.91Fe ( Li, G; Ling, J; Liu, X; Lu, W; Pan, C; Shen, T; Sun, J; Sun, W; Xu, S; Zhang, J; Zheng, J, 2023)
" Dopa-melanin and medium containing decomposed dopa were also selectively toxic to MM96 cells."1.27Modification of dopa toxicity in human tumour cells. ( Parsons, PG, 1985)

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-199019 (61.29)18.7374
1990's0 (0.00)18.2507
2000's5 (16.13)29.6817
2010's5 (16.13)24.3611
2020's2 (6.45)2.80

Authors

AuthorsStudies
Sun, W1
Xu, S1
Shen, T1
Li, G2
Zhang, J2
Pan, C1
Lu, W1
Liu, X1
Zheng, J1
Ling, J1
Sun, J1
Melo, BL1
Lima-Sousa, R1
Alves, CG1
Correia, IJ1
de Melo-Diogo, D1
Yang, N1
Tanner, JA1
Zheng, BJ1
Watt, RM1
He, ML1
Lu, LY1
Jiang, JQ1
Shum, KT1
Lin, YP1
Wong, KL1
Lin, MCM1
Kung, HF1
Sun, H1
Huang, JD1
Marinho, CC1
Nicolato, AJPG1
Reis, VW1
Dos Santos, RC1
Silva, JC1
Faria, HP1
Machado-Coelho, GLL1
Sun, Y2
Zhang, N1
Wang, J2
Guo, Y1
Sun, B1
Liu, W1
Zhou, H1
Yang, C1
Wei, L1
Ball, S1
Dennis, JA1
Bedanie, G1
Nugent, K1
Hayek, AJ1
Scott, V1
Yau, P1
Zolfaghari, K1
Goldwater, M1
Almquist, J1
Arroliga, AC1
Ghamande, S1
Wu, Q1
Ma, W1
Shi, R1
Zhang, B1
Mao, X1
Zheng, W1
Sbhatu, DB1
Berhe, GG1
Hndeya, AG1
Abraha, HB1
Abdu, A1
Gebru, HA1
Taye, MG1
Mulugeta, A1
Weldemichael, MY1
Tekle, HT1
Kidanemariam, HG1
Surger, M1
Angelov, A1
Liebl, W1
Hookey, L1
Bertiger, G1
Johnson, KL1
Boules, M1
Ando, M1
Dahdal, DN1
Riedl, JM1
Posch, F1
Prager, G1
Eisterer, W1
Oehler, L1
Sliwa, T1
Wilthoner, K1
Petzer, A1
Pichler, P1
Hubmann, E1
Winder, T1
Burgstaller, S1
Korger, M1
Andel, J1
Greil, R1
Neumann, HJ1
Pecherstorfer, M1
Philipp-Abbrederis, K1
Djanani, A1
Gruenberger, B1
Laengle, F1
Wöll, E1
Gerger, A1
Evans, WE1
Raynor, HA1
Howie, W1
Lipton, RB1
Thomas, GJ1
Wing, RR1
Pavlovic, J1
Farris, SG1
Bond, DS1
Hepprich, M1
Antwi, K1
Waser, B1
Reubi, JC1
Wild, D1
Christ, ER1
Braüner Christensen, J1
Aasbrenn, M1
Sandoval Castillo, L1
Ekmann, A1
Giver Jensen, T1
Pressel, E1
Haxholdt Lunn, T1
Suetta, C1
Palm, H1
Mansour, FA1
Al-Mazrou, A1
Al-Mohanna, F1
Al-Alwan, M1
Ghebeh, H1
Brown-Johnson, C1
Safaeinili, N1
Zionts, D1
Holdsworth, LM1
Shaw, JG1
Asch, SM1
Mahoney, M1
Winget, M1
Luo, Y1
Shan, H1
Gao, X1
Qi, P1
Li, Y2
Li, B1
Rong, X1
Shen, B1
Zhang, H1
Lin, F1
Tang, Z1
Fang, Z1
Peng, Z1
Jimenez, JL1
Ayer, GB1
Klepov, VV1
Pace, KA1
Zur Loye, HC1
Acquaroni, M1
Svartz, G1
Pérez Coll, C1
Otludil, B1
Ayaz, S1
Hill, A1
Elakkad, A1
Kuban, J1
Sabir, S1
Odisio, B1
Huang, SY1
Mahvash, A1
Miller, E1
Kroll, MH1
Overman, M1
Tam, AL1
Gupta, S1
Sheth, RA1
Deandreis, D1
Guarneri, A1
Ceci, F1
Lillaz, B1
Bartoncini, S1
Oderda, M1
Nicolotti, DG1
Pilati, E1
Passera, R1
Zitella, A1
Bellò, M1
Parise, R1
Carlevato, R1
Ricardi, U1
Gontero, P1
Coyne, GO'1
Wang, L2
Zlott, J1
Juwara, L1
Covey, JM1
Beumer, JH1
Cristea, MC1
Newman, EM1
Koehler, S1
Nieva, JJ1
Garcia, AA1
Gandara, DR1
Miller, B1
Khin, S1
Miller, SB1
Steinberg, SM1
Rubinstein, L1
Parchment, RE1
Kinders, RJ1
Piekarz, RL1
Kummar, S1
Chen, AP1
Doroshow, JH1
Li, X2
Chen, J2
Gan, L1
Tian, Y1
Shi, B1
Yang, Y1
Wu, D1
Wen, A1
Wu, Y1
Zhou, X1
Koyappayil, A1
Chavan, SG1
Mohammadniaei, M1
Go, A1
Hwang, SY1
Lee, MH1
Kurokawa, Y1
Yamashita, K1
Kawabata, R1
Fujita, J1
Imamura, H1
Takeno, A1
Takahashi, T1
Yamasaki, M1
Eguchi, H1
Doki, Y1
Schulte, T1
Sala, BM1
Nilvebrant, J1
Nygren, PÅ1
Achour, A1
Shernyukov, A1
Agback, T1
Agback, P1
Karami, H1
Shariatifar, N1
Nazmara, S1
Moazzen, M1
Mahmoodi, B1
Mousavi Khaneghah, A1
Sinha, N1
Mukhopadhyay, S1
Sau, M1
Qi, Y1
Wan, M1
Abd El-Aty, AM1
Li, H2
Cao, L1
She, Y1
Shao, Y1
Jin, F1
Wang, S1
Melendez-Araújo, MS1
Lemos, KGE1
Arruda, SLM1
Dutra, ES1
de Carvalho, KMB1
de la Plaza Llamas, R1
Díaz Candelas, DA1
Ramia, JM1
Zhu, S1
Liu, Z1
Lu, J2
Xiang, Z1
Lan, J1
Liu, J1
Yu, M1
Chen, Y2
Sirajudeen, AAO1
Annuar, MSM1
Subramaniam, R1
Somme, F1
Montaz-Rosset, MS1
Averous, G1
Deur, J1
Goichot, B1
Bachellier, P1
Addeo, P1
Imperiale, A1
Xu, L1
Li, Z2
Song, S1
Chen, Q1
Mo, L1
Wang, C1
Fan, W1
Yan, Y1
Tong, X1
Yan, H1
Singh, A1
Chen, HC1
Chen, YF1
Lu, YJ1
Wong, KT1
Chu, CW1
Banijamali, AR1
Carvalho, AE1
Wakefield, JD1
Germano, P1
Barden, TC1
Tobin, JV1
Zimmer, DP1
Masferrer, JL1
Profy, AT1
Currie, MG1
Todd Milne, G1
Zhang, Y1
Yang, H1
Dang, Z1
Zhan, S1
Sun, C1
Hu, G1
Lin, Y1
Yuan, Q1
Karayağiz Muslu, G1
Özdemir, M1
Del Prete, S1
Nocentini, A1
Supuran, CT1
Capasso, C1
Chagas, ATA1
Ludwig, S1
Pimentel, JDSM1
de Abreu, NL1
Nunez-Rodriguez, DL1
Leal, HG1
Kalapothakis, E1
Lin, L1
Dodig, D1
Kovačić, S1
Matana Kaštelan, Z1
Žuža, I1
Benić, F1
Slaven, J1
Miletić, D1
Rumboldt, Z1
Fernandez-Botran, R1
Wellmann, IA1
Une, C1
Méndez-Chacón, E1
Hernández de Rodas, E1
Bhandari, B1
Villagrán de Tercero, CI1
Nguyen, HTT1
Romano, F1
Wampfler, R1
Mühlethaler, K1
Tannich, E1
Oberli, A1
Yang, J1
Xiang, T1
Dai, L1
Zhao, X1
Ma, L1
Zuo, D1
Wei, B1
Sui, Y1
Xu, F1
Zheng, H1
Qiu, C1
Jin, H1
Kerwin, J1
Khan, I1
Rajasekhar, B1
Venkateshwaran, U1
Durairaj, N1
Divyapriya, G1
Nambi, IM1
Joseph, A1
Aliste, M1
Garrido, I1
Flores, P1
Hellín, P1
Vela, N1
Navarro, S1
Fenoll, J1
Guo, S1
Lin, CM1
Xu, Z1
Miao, L1
Wang, Y1
Huang, L1
Kim, BJ1
Cheong, H1
Hwang, BH1
Cha, HJ1
Chandramouly, G1
McDevitt, S1
Sullivan, K1
Kent, T1
Luz, A1
Glickman, JF1
Andrake, M1
Skorski, T1
Pomerantz, RT1
Bae, KH1
Lee, K1
Kim, C1
Park, TG1
Krämer, SD1
Mu, L1
Müller, A1
Keller, C1
Kuznetsova, OF1
Schweinsberg, C1
Franck, D1
Müller, C1
Ross, TL1
Schibli, R1
Ametamey, SM1
MONDER, C1
WAISMAN, HA1
BUTTLE, GA1
EPERON, J1
KAMESWARAN, L1
WEST, GB1
HEMPEL, K1
ERB, W1
DAY, M1
GREEN, JP1
BLOIS, MS1
KALLMAN, RF1
GJESSING, LR2
BORUD, O1
GREER, M1
ANTON, AH1
WILLIAMS, CM1
ECHEVARRIA, RA1
HIRSCH, HM1
Koopmans, KP1
de Vries, EG1
Kema, IP1
Elsinga, PH1
Neels, OC1
Sluiter, WJ1
van der Horst-Schrivers, AN1
Jager, PL1
Groves, AM1
Win, T1
Haim, SB1
Ell, PJ1
Vallabhajosula, S1
Bolster, JM1
Vaalburg, W1
Van Veen, W1
Van Dijk, T1
Van der Molen, HD1
Wynberg, H1
Woldring, MG1
Anderson, RR1
Parrish, JA1
Graham, MM1
Shishkina, VV1
Chebotareva, ED1
Bobrova, VN2
Korolev, VI1
Idlis, SM1
Vdovenko, VM1
Ivanov, II1
Rumjanceva, LN1
Sestakov, AD1
Gavrilenko, IS1
Cernyseva, LF1
Parsons, PG1
Käser, H3
Wagner, HP1
Zuppinger, K1
Zurbrügg, R1
Beutler, E1
Okun, MR1
Edelstein, L1
Niebauer, G1
Hamada, G1
Türler, K1
Ott, F1

Reviews

3 reviews available for dihydroxyphenylalanine and Benign Neoplasms

ArticleYear
Non-[18F]FDG PET in clinical oncology.
    The Lancet. Oncology, 2007, Volume: 8, Issue:9

    Topics: Antibodies; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Medical Onc

2007
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Seminars in nuclear medicine, 2007, Volume: 37, Issue:6

    Topics: Amino Acids; Animals; Bone and Bones; Cell Hypoxia; Choline; Dideoxynucleosides; Dihydroxyphenylalan

2007
Glucose-6-phosphate dehydrogenase deficiency.
    British journal of haematology, 1970, Volume: 18, Issue:2

    Topics: Black People; Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Favism; Female; Glucosephosphat

1970

Trials

1 trial available for dihydroxyphenylalanine and Benign Neoplasms

ArticleYear
    Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 2007, Aug-27, Volume: 119, Issue:34

    Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aer

2007

Other Studies

27 other studies available for dihydroxyphenylalanine and Benign Neoplasms

ArticleYear
Fe
    International journal of nanomedicine, 2023, Volume: 18

    Topics: Animals; Cell Line, Tumor; Contrast Media; Dihydroxyphenylalanine; Doxorubicin; Drug Delivery System

2023
Sulfobetaine methacrylate-coated reduced graphene oxide-IR780 hybrid nanosystems for effective cancer photothermal-photodynamic therapy.
    International journal of pharmaceutics, 2023, Nov-25, Volume: 647

    Topics: Cell Line, Tumor; Dihydroxyphenylalanine; Neoplasms; Photochemotherapy; Photosensitizing Agents; Pho

2023
Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.
    ACS nano, 2014, May-27, Volume: 8, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chromatography, High Pressure Liquid; C

2014
Mussel-Inspired Protein Nanoparticles Containing Iron(III)-DOPA Complexes for pH-Responsive Drug Delivery.
    Angewandte Chemie (International ed. in English), 2015, Jun-15, Volume: 54, Issue:25

    Topics: Animals; Antibiotics, Antineoplastic; Bivalvia; Delayed-Action Preparations; Dihydroxyphenylalanine;

2015
Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers.
    Chemistry & biology, 2015, Nov-19, Volume: 22, Issue:11

    Topics: Allosteric Regulation; Apoptosis; BRCA1 Protein; BRCA2 Protein; Cell Line; Cell Proliferation; Dihyd

2015
Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging.
    Biomaterials, 2011, Volume: 32, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Dihydroxyphenylalanine;

2011
5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:3

    Topics: Amino Acid Transport System L; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Ami

2012
The nonenzymic conversion of dopa to melanin. IV. The inhibition of copper-catalyzed dopa oxidation by human blood plasma in leukemia and cancer.
    Cancer research, 1959, Volume: 19, Issue:3 Pt 1

    Topics: Copper; Dihydroxyphenylalanine; Humans; Leukemia; Melanins; Neoplasms; Oxidation-Reduction

1959
Histamine formation and tumor growth.
    British journal of cancer, 1962, Volume: 16

    Topics: Animals; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Histamine; Liver Neoplasms; Liver Neopla

1962
[Autoradiographic studies on protein and melanin metabolism in different cell types in melanoma in mice (Harding-Passey type)].
    Zeitschrift fur Zellforschung und mikroskopische Anatomie (Vienna, Austria : 1948), 1962, Volume: 58

    Topics: Animals; Autoradiography; Dihydroxyphenylalanine; Melanins; Melanoma; Mice; Neoplasms; Neoplasms, Ex

1962
The uptake of amino acids and the synthesis of amines by neoplastic mast cells in culture.
    The Journal of physiology, 1962, Volume: 164

    Topics: Amines; Amino Acids; Dihydroxyphenylalanine; Histamine; Histidine; Mast Cells; Neoplasms; Neoplasms,

1962
THE INCORPORATION OF C14 FROM 3,4-DIHYDROXYPHENYLALANINE-2'-C14 INTO THE MELANIN OF MOUSE MELANOMAS.
    Cancer research, 1964, Volume: 24

    Topics: Animals; Carbon Isotopes; Dihydroxyphenylalanine; Melanins; Melanoma; Metabolism; Mice; Neoplasms; N

1964
STUDIES OF FUNCTIONAL NEURAL TUMORS. VI. BIOCHEMICAL DIAGNOSIS.
    Scandinavian journal of clinical and laboratory investigation, 1964, Volume: 16

    Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Amino Acids; Child; Dihydroxyphenylalanine

1964
STUDIES OF FUNCTIONAL NEURAL TUMORS. VII. URINARY EXCRETION OF PHENOLIC PYRUVIC ACIDS.
    Scandinavian journal of clinical and laboratory investigation, 1965, Volume: 17

    Topics: Alkylation; Child; Chromatography; Dihydroxyphenylalanine; Humans; Metabolism; Neoplasm Metastasis;

1965
TUMORS OF NEURAL CREST ORIGIN; BIOCHEMICAL AND PATHOLOGICAL CORRELATION.
    Archives of neurology, 1965, Volume: 13

    Topics: Biochemical Phenomena; Biochemistry; Catecholamines; Child; Dihydroxyphenylalanine; Dopamine; Epinep

1965
Tissue autoxidation inhibitors. I. The inhibition of DOPA autoxidation by extracts from normal and neoplastic tissues.
    Cancer research, 1955, Volume: 15, Issue:4

    Topics: Dihydroxyphenylalanine; Neoplasms; Oxidation-Reduction

1955
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
    The Lancet. Oncology, 2006, Volume: 7, Issue:9

    Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male;

2006
Synthesis of no-carrier-added L- and D-[1-11C]-DOPA.
    The International journal of applied radiation and isotopes, 1983, Volume: 34, Issue:12

    Topics: Brain; Dihydroxyphenylalanine; Humans; Isotope Labeling; Levodopa; Neoplasms; Radionuclide Imaging

1983
Lasers in dermatology provide a model for exploring new applications in surgical oncology.
    International advances in surgical oncology, 1982, Volume: 5

    Topics: Animals; Black People; Dermatologic Surgical Procedures; Dihydroxyphenylalanine; Hemangioma; Humans;

1982
Combined 18F-FDG-FDOPA tumor imaging for assessing response to therapy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:2

    Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasms; Radiopharmaceuticals; T

2001
[Characteristics of distribution and elimination of DOPA-H3 and naphthidone-H3 in various forms of tumors].
    Vrachebnoe delo, 1978, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Autoradiography; Dihydroxyphenylalanine; Female; Hum

1978
[Possibilities of using tritium in the intratissue rachiotheraphy of tumors].
    Radiobiologia, radiotherapia, 1975, Volume: 16, Issue:1

    Topics: Chemical Phenomena; Chemistry; Cyclophosphamide; Dihydroxyphenylalanine; Humans; Melanoma; Neoplasms

1975
Modification of dopa toxicity in human tumour cells.
    Biochemical pharmacology, 1985, May-15, Volume: 34, Issue:10

    Topics: Adenoviruses, Human; Adult; Cell Line; Cell Survival; Dihydroxyphenylalanine; DNA; Humans; Male; Neo

1985
[Biochemical tumor diagnosis in childhood].
    Schweizerische medizinische Wochenschrift, 1974, May-04, Volume: 104, Issue:18

    Topics: Adenoma, Islet Cell; Adrenal Gland Neoplasms; Carcinoma, Hepatocellular; Child; Cushing Syndrome; De

1974
[Biochemical diagnosis of pheochromocytoma, neuroblastoma and other neuro-ectodermal neoplasms].
    Helvetica paediatrica acta, 1972, Volume: 29

    Topics: Adolescent; Adult; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Dopamine; Electr

1972
The histochemical tyrosine-dopa reaction for tyrosinase and its use in localizing tyrosinase activity in mast cells.
    The Journal of investigative dermatology, 1969, Volume: 53, Issue:1

    Topics: Animals; Catechol Oxidase; Dihydroxyphenylalanine; Histocytochemistry; Humans; Mast Cells; Melanoma;

1969
[Biochemical studies of malignant melanoma].
    Schweizerische medizinische Wochenschrift, 1970, Jun-06, Volume: 100, Issue:23

    Topics: Adult; Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Flavoring Agents; Humans; Lactates; Me

1970